One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-151054
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 1 |
Affiliation: Swedish Medical Center, Mountain Blue Cancer Care Center, Sarah Cannon, Rush University Medical Center, Texas Oncology, Rocky Mountain Cancer Centers, Florida Cancer Specialists & Research Institute, CDG Therapeutics (United States), Norton Healthcare, The Maria Sklodowska-Curie National Research Institute of Oncology, Oncology Hematology Care, Wroclaw Medical University, Levine Cancer InstituteEfficacy and Safety of Umbralisib, Ublituximab (U2), and U2 Plus Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
